Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: Generation and evaluation of 4-[ 18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin αvβ6 expression with positron emission tomography

Cancer Research

Volumn 67, Issue 16, 2007, Pages 7833-7840

  Hausner, Sven H ^a   DiCara, Danielle ^b   Marik, Jan ^a   Marshall, John F ^b   Sutcliffe, Julie L ^a  

^a University of California   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 FLUOROBENZOIC ACID F 18; ALPHAVBETA6 INTEGRIN; BENZOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FOOT AND MOUTH DISEASE VIRUS; HUMAN; HUMAN CELL; IN VIVO STUDY; ISOTOPE LABELING; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; BENZOIC ACIDS; BINDING, COMPETITIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE VIRUS; HUMANS; INTEGRINS; ISOTOPE LABELING; MALE; MELANOMA; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; VIRAL ENVELOPE PROTEINS;

EID: 34548007871     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1026     Document Type: Article

References (43)

1. Cherry SR. The 2006 Henry N. Wagner lecture: of mice and men (and positrons)-advances in PET imaging technology. J Nucl Med 2006;47:1735-45.
2. Kelloff G, Hoffman JM, Johnson B, et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 2005;11:2785-808.
3. Kelloff GJ, Krohn KA, Larson SM, et al. The progress and promise of molecular imaging probes in oncologic drug development. Clin Cancer Res 2005;11:7967-85.
4. 6 integrin ligands. J Biol Chem 2007;282:9657-65.
5. Hynes RO. Integrins: Bidirectional, allosteric signaling machines. Cell 2002;110:673-87.
6. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996;12:697-715.
7. 3-Integrin imaging: a new approach to characterise angiogenesis? Eur J Nucl Med Mol Imaging 2006;33:S54-63.
8. Meyer A, Auernheimer J, Modlinger A, Kessler H. Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging, and targeting. Curr Pharm Des 2006;12:2723-47.
9. 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res 2001;61:1781-5.
10. 18FFRGD2. J Nucl Med 2006;47:113-21.
11. 3 targeted radiotracers for tumor imaging. Mol Pharmaceutics 2006;3:472-87.
12. 6 Integrin in wound healing and cancer of the oral cavity. J Oral Pathol Med 2006;35:1-10.
13. 6 integrin subunit in development, neoplasia, and tissue-repair suggests a role in epithelial remodeling. J Cell Sci 1995;108:2241-51.
14. 6 is associated with lymph node metastasis. Pathol Res Pract 2003;199:57-64.
15. 6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 2005;115:339-47.
16. 6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer 2001;92:641-50.
17. 6integrin-dependent oral squamous carcinoma invasion. Cancer Res 2006;66:10833-42.
18. Janes SM, Watt FM. New roles for integrins in squamous-cell carcinoma. Nat Rev Cancer 2006;6:175-83.
19. Rumboldt Z, Day TA, Michel M. Imaging of oral cavity cancer. Oral Oncol 2006;42:854-65.
20. Cancer Statistics Registrations: Series MB1 No. 21. Office of Population Censuses and Surveys (OPCS). London: HMSO; 1994.
21. 18F-labelled linear peptides. Eur J Nucl Med Mol Imaging 2002;29:754-9.
22. 18F]fluoropropionyl peptides. Bioconjugate Chem 2006;17:1017-21.
23. I catalyzed 1,3-dipolar cycloaddition. Tetrahedron Lett 2006;47:6681-4.
24. 18F]fluorobenzoate using a Siemens/CTI chemistry process control unit (CPCU). Appl Radiat Isot 2007;65:199-203.
25. 18F] fluoropropionyl-(D)phe(1))-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET - synthesis, radiolabeling, in vitro validation, and biodistribution in mice. Nucl Med Biol 1994;21:819-25.
26. 18F]fluorobenzoate. Appl Radiat Isot 2003;59:43-8.
27. 18F-labeled RGD and octreotide analogs. J Nucl Med 2004;45:892-902.
28. Logan D, Abu-Ghazaleh R, Blakemore W, et al. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 1993;362:566-8.
29. 6 is a receptor for foot-and-mouth disease virus. J Virol 2000;74:4949-56.
30. 6 integrin receptor for foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J Gen Virol 2005;86:2769-80.
31. v integrins. J Virol 2006;80:9798-810.
32. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 1989;337:709-16.
33. 6 integrin. J Biol Chem 1999;274:1979-85.
34. Mateu MG, Valero ML, Andreu D, Domingo E. Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition. J Biol Chem 1996;271:12814-9.
35. Jackson T, King AMQ, Stuart DI, Fry E. Structure and receptor binding. Virus Res 2003;91:33-46.
36. 3 integrin for a new cancer therapy. Angew Chem Int Ed Engl 1997;36:1375-89.
37. 6 in cell attachment to fibronectin - heterologous expression of intact and secreted forms of the receptor. J Biol Chem 1994;269:6940-8.
38. Hancock WS, Battersby JE. New micro-test for detection of incomplete coupling reactions in solid-phase peptide-synthesis using 2,4,6- trinitrobenzenesulphonic acid. Anal Biochem 1976;71:260-4.
39. McCusker CF, Kocienski PJ, Boyle FT, Schatzlein AG. Solid-phase synthesis of c(RGDfK) derivatives: on-resin cyclisation and lysine functionalisation. Bioorg Med Chem Lett 2002;12:547-9.
40. Defrise M, Kinahan PE, Townsend DW, Michel C, Sibomana M, Newport DF. Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans Med Imag 1997;16:145-58.
41. Qi JY, Leahy RM, Cherry SR, Chatziioannou A, Farquhar TH. High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner. Phys Med Biol 1998;43:1001-13.
42. v-integrins in tumour progression and metastasis. Semin Cancer Biol 1996;7:129-38.
43. Gasteiger E, Hoogland C, Gattiker A, et al. Protein identification and analysis tools on the ExPASy server. In: Walker JM, editor. The proteomics protocols handbook. Totowa: Humana Press; 2005. Available from: http://www.expasy.org/tools/peptidecutter/.